Publications
2025
Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.
Sarker, C., Jorgensen, A. L., Tharmaratnam, K., Al-Abadi, E., Armon, K., Bailey, K., . . . Md Smith, E. (2025). Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.. Rheumatology (Oxford, England), keaf057. doi:10.1093/rheumatology/keaf057
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.
Sadun, R. E., Cooper, J. C., Belot, A., Avcin, T., Aggarwal, A., Ainsworth, J., . . . CARRA SLE Committee and PReS Lupus Working Party. (2025). Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.. Annals of the rheumatic diseases, 84(2), 158-168. doi:10.1136/ard-2024-226528
2024
Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis.
Tordoff, M., Smith, S. L., Lawson-Tovey, S., Dick, A. D., Beresford, M. W., Ramanan, A. V., . . . CLUSTER Consortium. (2024). Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis.. Arthritis & rheumatology (Hoboken, N.J.), 76(12), 1789-1796. doi:10.1002/art.42955
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.
Sadun, R. E., Cooper, J. C., Belot, A., Avcin, T., Aggarwal, A., Ainsworth, J., . . . CARRA SLE Committee and PReS Lupus Working Party. (2024). Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.. Annals of the rheumatic diseases, ard-2024-226528. doi:10.1136/ard-2024-226528
Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study.
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Douglas, S., Foster, H. E., Southwood, T. R., . . . UK JIA Biologics Register. (2024). Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study.. The Lancet. Rheumatology, 6(7), e438-e446. doi:10.1016/s2665-9913(24)00087-0
POS0304 ALLELE COUNTS ASSOCIATE WITH EARLY DISEASE ONSET, ORGAN INVOLVEMENT AND DISEASE SEVERITY IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
Natoli, V., Charras, A., Hasoon, M., Caamano Gutierrez, E., MD Smith, E., Beresford, M. W., & Hedrich, C. M. (2024). POS0304 ALLELE COUNTS ASSOCIATE WITH EARLY DISEASE ONSET, ORGAN INVOLVEMENT AND DISEASE SEVERITY IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. In Annals of the Rheumatic Diseases Vol. 83 (pp. 261-262). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.1103
Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Marks, S. D. (2024). Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.. Clinical immunology (Orlando, Fla.), 110214. doi:10.1016/j.clim.2024.110214
Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.
Renaudineau, Y., Charras, A., Natoli, V., Fusaro, M., Smith, E. M. D., Beresford, M. W., . . . UK jSLE Cohort Study. (2024). Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.. Clinical immunology (Orlando, Fla.), 262, 110194. doi:10.1016/j.clim.2024.110194